advertisement
 

  Back to Current Daily Care News Daily Care News from 2009

Daily Care News from 2009

    30 December 2009

  1. Missed Insulin Boluses for Snacks in Youth with Type 1 Diabetes.
  2. Health-related quality of life in patients with type 1diabetes--association with diabetic complications (the FinnDiane Study).
  3. An Internet-Based Program to Improve Self-Management in Adolescents with Type 1 Diabetes.
  4. Insulin, metformin and cancer risk: A discussion of possible links.
  5. 23 December 2009

  6. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.
  7. Time lag characterization of two continuous glucose monitoring systems.
  8. New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time.
  9. Difference in insulin usage patterns with pubertal development in children with type 1 diabetes during transition from multiple daily injections to continuous subcutaneous insulin infusion (CSII) and through the CSII treatment.
  10. Long-term evaluation of patients with type 1 diabetes mellitus treated with insulin glargine.
  11. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction.
  12. Transition from pediatric to adult diabetes care: smooth or slippery?
  13. Long-term detrimental consequences of the onset of type 1 diabetes on annual earnings-evidence from annual registry data in 1990-2005.
  14. Cerebral Metabolic Alterations in Rats with Diabetic Ketoacidosis: Effects of Treatment with Insulin and Intravenous Fluids and Effects of Bumetanide.
  15. Post-mortem pathologic and genetic studies in "dead in bed syndrome" cases in type 1 diabetes mellitus.
  16. 16 December 2009

  17. Motor vehicle crashes in diabetic patients with tight glycemic control: a population-based case control analysis.
  18. Hypoglycemia in type 1 diabetic pregnancy: the role of pre-conception insulin aspart treatment in a randomized study.
  19. Teenage pregnancy in type 1 diabetes mellitus.
  20. A personalized approach to exercise promotion in adolescents with type 1 diabetes.
  21. Racial and Ethnic Differences in an Estimated Measure of Insulin Resistance Among Individuals with Type 1 Diabetes.

    9 December 2009

  22. Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit.

    2 December 2009

  23. Driving Mishaps Among Individuals With Type 1 Diabetes. Free full text available in HTML and PDF formats.
  24. Association Between Adherence and Glycemic Control in Pediatric Type 1 Diabetes: A Meta-analysis.
  25. Transition to Adult Care for Youths With Diabetes Mellitus: Findings From a Universal Health Care System.
  26. Teenagers' perceptions of factors affecting decision-making competence in the management of type 1 diabetes.
  27. Severe hypoglycaemia in type 1 diabetes: impact of the renin-angiotensin system and other risk factors.
  28. Atypical Symptoms Seen in Teens with Type 1 Diabetes.

    25 November 2009

  29. Physicians' Perceptions of Reimbursement as a Barrier to Comprehensive Diabetes Care. Free full text available in PDF format. See also Doctors Say Low Pay for Diabetes Care Shortchanges Patients.
  30. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial.
  31. Relapse of diabetic ketoacidosis secondary to insulin pump malfunction diagnosed by capillary blood 3-hydroxybutyrate: a case report.
  32. Improving adherence in social situations for adolescents with type 1 diabetes mellitus (T1DM): A pilot study.
  33. Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes.

    18 November 2009

  34. Insulin pump therapy management in very young children with type 1 diabetes using continuous subcutaneous insulin infusion.
  35. Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins.
  36. Increased prevalence of burnout symptoms in parents of chronically ill children.
  37. Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patients.
  38. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes.
  39. Continuous glucose monitor shows potential for early hypoglycemia detection in hospitalized patients.
  40. A Comparison of Costs among Patients with Type 2 Diabetes Mellitus Who Initiated Therapy with Exenatide or Insulin Glargine.
  41. Deleterious associations of sitting time and television viewing time with cardio-metabolic risk biomarkers: AusDiab 2004–2005.

    11 November 2009

  42. Use of insulin glargine in type 1 diabetes children with less than eight years old.
  43. Use of Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy in the Hospital: A Review of One Institution's Experience.
  44. Effects of a Mixed Meal on Hemodynamics and Autonomic Control of the Heart in Patients with Type 1 Diabetes.
  45. The 600-step program for type 1 diabetes self-management in youth: the magnitude of the self-management task.
  46. A Pilot Study of Observed Parenting and Adjustment in Adolescents with Type 1 Diabetes and their Mothers.

    4 November 2009

  47. Association Between Adherence and Glycemic Control in Pediatric Type 1 Diabetes: A Meta-analysis.
  48. Family functioning at meals relates to adherence in young children with type 1 diabetes.
  49. Feeding problems reported by parents of young children with type 1 diabetes on insulin pump therapy and their associations with children's glycemic control.
  50. Improved metabolic outcome in a Danish diabetic paediatric population aged 0–18 yr: results from a nationwide continuous Registration.
  51. The 25-Year Incidence of Visual Impairment in Type 1 Diabetes Mellitus The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
  52. Individual Growth Curve Modeling of Specific Risk Factors and Memory in Youth with Type 1 Diabetes: An Accelerated Longitudinal Design.
  53. Lifetime prevalence of suicidal and self-injurious behaviors in a representative cohort of Slovenian adolescents with type 1 diabetes.
  54. Ketoacidosis at presentation of type 1 diabetes in children in Kuwait: frequency and clinical characteristics.

    28 October 2009

  55. A Pilot Trial of Pramlintide Home Usage in Adolescents With Type 1 Diabetes.
  56. Microalbuminuria, preeclampsia and preterm delivery in pregnant women with type 1 diabetes - results from a nation-wide Danish study.
  57. Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes.
  58. Optimal Insulin Treatment in Type 2 Diabetes. Free full text available in PDF format.
  59. 21 October 2009

  60. Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment: Evidence from the JDRF-CGM Trial.
  61. Use of continuous glucose monitoring system in the management of severe hypoglycemia.
  62. Confirmation of Hypoglycemia in the 'Dead-in-Bed' Syndrome as Captured by a Retrospective Continuous Glucose Monitoring System.
  63. Nocturnal Blood Glucose and IGFBP-1 Changes in Type 1 Diabetes: Differences in the Dawn Phenomenon between Insulin Regimens.
  64. Diabetic Ketoacidosis and Memory Dysfunction in Children with Type 1 Diabetes.
  65. 14 October 2009

  66. Disaster Preparedness in Pediatric Type 1 Diabetes Mellitus.
  67. The role of parent-adolescent attachment in the glycemic control of adolescents with type 1 diabetes: A pilot study.

    7 October 2009

  68. Patterns of youths' glycemic control with insulin pump therapy.
  69. Insulin Glargine Safety in Pregnancy: a Transplacental Transfer Study.
  70. Menstrual cycle irregularities and their relationship with HbA1c and insulin dose in adolescents with type 1 diabetes mellitus.
  71. Sexual Functioning among Women with and without Diabetes in the Boston Area Community Health Study.
  72. "Diabetes Interactive Diary" (DID): a new telemedicine system enabling flexible diet and insulin therapy while improving the quality of life: an open label, international, multicentre, randomized study.
  73. Postprandial Vascular Effects of Viaject™ compared with Insulin Lispro and Regular Human Insulin in Patients with Type 2 Diabetes Mellitus.

    30 September 2009

  74. Improvements in life expectancy in type 1 diabetes patients in the last six decades.

    23 September 2009

  75. Combined randomised controlled trial experience of malignancies in studies using insulin glargine.
  76. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: The RealTrend study.
  77. Sociodemographic and psychosocial factors associated with continuous subcutaneous insulin infusion in adolescents with type 1 diabetes.
  78. The Median Is Not the Only Message: A Clinician's Perspective on Mathematical Analysis of Glycemic Variability and Modeling in Diabetes Mellitus. Free full text available in HTML and PDF formats.
  79. Cataract surgery in a population-based cohort of patients with type 1 diabetes: long-term incidence and risk factors.
  80. Risk markers of future microalbuminuria and hypertension based on clinical and morphological parameters in young type 1 diabetes patients.
  81. Daily vegetable intake during pregnancy negatively associated to islet autoimmunity in the offspring-The ABIS study.
  82. Cognitive Function and Event-Related Potentials in Children With Type 1 Diabetes Mellitus.
  83. Successful treatment of severe subcutaneous insulin resistance with inhaled insulin therapy.

    16 September 2009

  84. Emphasis on Carbohydrates May Negatively Influence Dietary Patterns in Youth with Type 1 Diabetes.
  85. Managing type 1 diabetes: trends and outcomes over 20 years in the Wisconsin Diabetes Registry cohort.
  86. Healthcare routines of university students with Type 1 diabetes.
  87. Accuracy of the SEVEN® Continuous Glucose Monitoring System: Comparison with Frequently Sampled Venous Glucose Measurements. (PDF)
  88. Clinically Significant Disagreement between Mean Blood Glucose and Estimated Average Glucose in Two Populations: Implications for Diabetes Management. (PDF)
  89. Comparison of Lancing Devices for Self-Monitoring of Blood Glucose Regarding Lancing Pain. (PDF)
  90. Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection.
  91. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.

    9 September 2009

  92. Salivary Antioxidants in Patients With Type 1 or 2 Diabetes and Inflammatory Periodontal Disease: A Case-Control Study.
  93. Diabetes-specific family conflict and psychological distress in paediatric Type 1 diabetes.
  94. Hub-and-spoke model for a 5-day structured patient education programme for people with Type 1 diabetes.

    2 September 2009

  95. Hospitalization Subsequent to Diagnosis in Young Patients With Diabetes in Chicago, Illinois.
  96. Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine.
  97. An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK.
  98. Severe hypoglycaemia during pregnancy in women with Type 1 diabetes is common and planning pregnancy does not decrease the risk.
  99. Initial insulin therapy in children and adolescents with type 1 diabetes mellitus.
  100. Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes.
  101. Impact of xerostomia on the quality of life of adolescents with type 1 diabetes mellitus.

    26 August 2009

  102. Psychosocial problems in adolescents with type 1 diabetes mellitus.
  103. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
  104. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
  105. Accuracy and reliability of continuous glucose monitoring in individuals with type 1 diabetes during recreational diving.
  106. Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe.
  107. Cause of death in infants of women with pregestational diabetes mellitus and the relationship with glycemic control.

    19 August 2009

  108. Sustained Benefit of Continuous Glucose Monitoring on HbA1c, Glucose Profiles, and Hypoglycemia in Adults with Type 1 Diabetes.
  109. Factors Predictive of Use and of Benefit from Continuous Glucose Monitoring in Type 1 Diabetes.
  110. The effectiveness of glucose, sucrose, and fructose in treating hypoglycemia in children with type 1 diabetes.
  111. Blunted Counter-regulatory Hormone Responses to Hypoglycemia in Young Children and Adolescents with Well-controlled Type 1 Diabetes.
  112. Anxiety Symptoms in Adolescents with Type 1 Diabetes: Association with Blood Glucose Monitoring and Glycemic Control.
  113. Transition process of patients with type 1 diabetes (T1DM) from paediatric to the adult health care service: a hospital-based approach.
  114. Obstetric and perinatal outcomes in type 1 diabetic pregnancies – a large, population-based study.

    12 August 2009

  115. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.
  116. Insulin therapy and quality of life. A review.
  117. Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in Brazil.

    5 August 2009

  118. Evidence-based insulin treatment in type 1 diabetes mellitus.
  119. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus-a large-scale multicentre pilot study.
  120. Living with type 1 diabetes: perceptions of children and their parents.
  121. Glycemic Control in Youth with Diabetes: The SEARCH for Diabetes in Youth Study.
  122. Does brittle diabetes exist as a clinical entity? Free Portuguese language full text available in HTML and PDF formats.
  123. Risk factors for childhood overweight in offspring of type 1 diabetic women with adequate glycemic control during pregnancy: nationwide follow-up study in the Netherlands.
  124. Pregnancy Outcomes in Diabetes Subtypes: How Do They Compare? A Province-based Study of Ontario, 2005-2006.
  125. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.

    29 July 2009

  126. Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration. See also Intensive Glucose Control Halves Complications of Longstanding Type 1 Diabetes, Clinical Course of Type 1 Diabetes Called Much Improved and Tight Management of Type 1 Diabetes Worth the Effort; Rates of serious complications drop with intensive therapy, study shows.
  127. Benefits of Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Previously Treated with Multiple Daily Injections with Once-daily Glargine and Pre-meal Analogues.
  128. Nighttime caregiving behaviors among parents of young children with Type 1 diabetes: Associations with illness characteristics and parent functioning.
  129. Dyadic measures of the parent-child relationship during the transition to adolescence and glycemic control in children with type 1 diabetes.
  130. Prevalence of diabetic retinopathy in patients with type 1 diabetes mellitus. Free full text available in HTML and PDF formats.

    22 July 2009

  131. Insulin Glargine and Cancer—An Unsubstantiated Allegation.
  132. Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus.
  133. Continuous glucose monitoring in youth with type 1 diabetes.
  134. Associations of Parent Coping, Stress, and Well-Being in Mothers of Children with Diabetes: Examination of Data from a National Sample.
  135. Compensatory beliefs about glucose testing are associated with low adherence to treatment and poor metabolic control in adolescents with type 1 diabetes.
  136. Changes in Visual Impairment Prevalence by Period of Diagnosis of Diabetes The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
  137. Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes.
  138. Abnormal cold perception in the lower limbs: A sensitive indicator for detection of polyneuropathy in patients with type 1 diabetes mellitus.
  139. Low dose (0.05 units/kg/h) is comparable with standard dose (0.1 units/kg/h) intravenous insulin infusion for the initial treatment of diabetic ketoacidosis in children with type 1 diabetes-an observational study.
  140. Diabetes mellitus and gastric emptying: questions and issues in clinical practice.
  141. Insulin pump therapy for type 1 diabetes treatment in a girl with Down's syndrome.

    15 July 2009

  142. Nocturnal hypoglycaemia in type 1 diabetes--frequency and predictive factors.
  143. Impaired awareness of hypoglycemia in a population-based sample of children and adolescents with type 1 diabetes.
  144. Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria.
  145. Does Diabetes Double the Risk of Depression? Free full text available in HTML and PDF formats.
  146. Periodontal status in children and adolescents with type 1 diabetes mellitus.
  147. Risk factors for mortality and ischemic heart disease in patients with long-term type 1 diabetes.
  148. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
  149. Glycaemic risk assessment in children and young people with Type 1 diabetes mellitus.
  150. Experiences of professional support during pregnancy and childbirth - a qualitative study of women with type 1 diabetes. Free full text available in PDF format.
  151. Insulin analogs and pregnancy: an update.
  152. The effect of telemedicine on outcome and quality of life in pregnant women with diabetes.

    1 July 2009

  153. From Diabetelogia, the journal of the European Association for the Study of Diabetes: Lantus insulin: a possible link with cancer which requires further investigation. The science and a statement from Sanofi-Aventis are freely available at that link in PDF form. See also Sanofi-aventis stands behind the safety of Lantus® (PDF), Lantus®: message from Dr. Jean-Pierre Lehner, sanofi-aventis Chief Medical Officer (video and PDFs), European Medicines Agency update on safety of insulin glargine (PDF), European Public Assessment report on Lantus (PDF), Points to consider on the Non-clinical assessment of the carcinogenic potential of human insulin analogues (PDF) from 2001, Statement from the American Diabetes Association Related to Studies Published in 'Diabetelogia', and Companies counter insulin safety concerns.
  154. Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria.
  155. Continuous subcutaneous insulin infusion versus multiple daily injections.
  156. Poor vitamin C status is associated with increased carotid intima-media thickness, decreased microvascular function, and delayed myocardial repolarization in young patients with type 1 diabetes.
  157. The establishment of a new national network leads to quality improvement in childhood diabetes: Implementation of the ISPAD Guidelines.
  158. Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.
  159. Pediatric Type 1 Diabetes Linked to Excess Weight.
  160. High prevalence of Mycobacterium tuberculosis infection and disease in children and adolescents with type 1 diabetes mellitus.
  161. Animal insulin therapy induces a biased insulin antibody response that persists for years after introduction of human insulin.

    24 June 2009

  162. Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicentre analysis of 14,664 patients from 106 institutions.
  163. Effects of a Higher-Carbohydrate/Lower-Fat Diet Versus a Lower-Carbohydrate/Higher-Fat-Monounsaturated Diet on Postmeal Triglyceride Concentrations and other Cardiovascular Risk Factors in Type 1 Diabetes.
  164. Prospective assessment of continuous subcutaneous insulin infusion therapy in young children with type 1 diabetes.
  165. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
  166. Short sleep duration is associated with blood pressure non dipping pattern in type 1 diabetes: The DIAPASOM study.
  167. Follow-up results on monitoring and discussing health-related quality of life in adolescent diabetes care: benefits do not sustain in routine practice.
  168. First Trimester Fasting Hyperglycemia and Adverse Pregnancy Outcomes.
  169. Disparities in self-monitoring of blood glucose among low-income ethnic minority populations with diabetes, United States.

    17 June 2009

  170. Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology.
  171. Insulin pump for treatment of children and adolescents with diabetes. Free Norwegian language full text available in HTML format.
  172. Intensive vs. conventional insulin management initiated at diagnosis in children with diabetes: Should payer source influence the choice of therapy?
  173. Monitoring of 24-h ECG and glucose level for detection of relations between glycemia and QT interval duration in type 1 diabetics.
  174. Subcutaneous antihistamine injection is effective to control a local allergic reaction to human insulin.

    10 June 2009

  175. Type 1 diabetes mellitus and school: a comparison of patients and healthy siblings.
  176. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis.
  177. Feeding problems reported by parents of young children with type 1 diabetes on insulin pump therapy and their associations with children's glycemic control.
  178. Effects of different antecedent increases of plasma cortisol on counterregulatory responses during subsequent exercise in type 1 diabetes.
  179. Prediction of albuminuria by different blood pressure measurement methods in type 1 diabetes: a pilot study.
  180. Tubular and glomerular injury in diabetes and the impact of ACE inhibition.
  181. Frequency and motives of blood glucose self-monitoring in type 1 diabetes.
  182. Adherence and Glycemic Control among Hispanic Youth with Type 1 Diabetes: Role of Family Involvement and Acculturation.
  183. Lifetime prevalence of suicidal and self-injurious behaviors in a representative cohort of Slovenian adolescents with type 1 diabetes.

    3 June 2009

  184. Continuous glucose monitoring beneficial for adults, children with well-controlled type 1 diabetes comments on The Effect of Continuous Glucose Monitoring in Well-controlled Type 1 Diabetes, previously reported.
  185. Changes in Basal Insulin Infusion Rates with CSII: Time until a Change in Metabolic Effect is Induced in Patients with Type 1 Diabetes.
  186. The effects of acute insulin-induced hypoglycemia on spatial abilities in adults with type 1 diabetes.
  187. Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).
  188. Difficulties or mistakes in diagnosing type 1 diabetes in children?—demographic factors influencing delayed diagnosis.
  189. Adult stature and diabetic complications in patients with type 1 diabetes.
  190. Everyday experience of families three years after diagnosis of type 1 diabetes in children: a research paper.
  191. Adherence to the DASH Diet is Inversely Associated with Incidence of Type 2 Diabetes: The Insulin Resistance Atherosclerosis Study.

    27 May 2009

  192. School-Centered Telemedicine for Children with Type 1 Diabetes Mellitus.
  193. Evaluation of daily glycemic profiles in well controlled children with type 1 diabetes mellitus using a continuous glucose monitoring system.
  194. Predictors of parental interest in continuous glucose monitoring for children with type 1 diabetes.
  195. Pramlintide Lowered Glucose Excursions and Was Well-Tolerated in Adolescents with Type 1 Diabetes: Results from a Randomized, Single-Blind, Placebo-Controlled, Crossover Study.
  196. Use of non-mydriatic retinography to determine the prevalence of diabetic retinopathy in diabetic patients.
  197. Oral health knowledge and habits in children with type 1 diabetes mellitus. Free full text available in HTML and PDF formats.
  198. Flow rate, pH and calcium concentration of saliva of children and adolescents with type 1 diabetes mellitus. Free full text available in HTML and PDF formats.
  199. Quality of life and associated factors among Jordanian adolescents with type 1 diabetes mellitus.
  200. Peri-Conceptional A1C and Risk of Serious Adverse Pregnancy Outcome in 933 Women With Type 1 Diabetes.
  201. Sexual Dysfunction and Symptom Impact in Men with Long-Standing Type 1 Diabetes in the DCCT/EDIC Cohort.

    20 May 2009

  202. Self-concept, attitude toward illness and family functioning in adolescents with type 1 diabetes.
  203. A case of severe, refractory diabetic gastroparesis managed by prolonged use of aprepitant.
  204. Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial.

    13 May 2009

  205. The Effect of Continuous Glucose Monitoring in Well-controlled Type 1 Diabetes.
  206. Twenty-Four-Hour Simultaneous Subcutaneous Basal-Bolus Administration of Insulin and Amylin in Adolescents with Type 1 Diabetes Decreases Postprandial Hyperglycemia.
  207. Effect of coffee and tea on the glycaemic index of foods: no effect on mean but reduced variability.
  208. New Definition for the Partial Remission Period in Children and Adolescents with T1D.
  209. A UK wide survey of insulin initiation in children with type 1 diabetes and nurses' perceptions of associated decision-making.
  210. Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect.

    6 May 2009

  211. Chronic sorrow in parents of children with type 1 diabetes.
  212. Coping and Psychosocial Adjustment in Mothers of Young Children with Type 1 Diabetes.
  213. Cognitive functions and glycemic control in children and adolescents with type 1 diabetes.
  214. Final size attained in type 1 diabetes children.
  215. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.

    29 April 2009

  216. Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion.
  217. Predictors of Insulin Regimens and Impact on Outcomes in Youth with Type 1 Diabetes: The SEARCH for Diabetes in Youth Study.
  218. Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada.
  219. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial.
  220. Realistic Expectations and Practical Use of Continuous Glucose Monitoring For the Endocrinologist.
  221. Comparison of a Multiple Daily Insulin Injection Regime (Basal Once-Daily Glargine plus Mealtime Lispro) and CSII (Lispro) in Type 1 Diabetes: a Randomized Open Parallel Multicenter Study.
  222. Hypoglycemia unawareness is associated with reduced adherence to therapeutic decisions in patients with type 1 diabetes: evidence from a clinical audit.
  223. The Impact of Managing School-aged Children's Diabetes: The Role of Child Behavior Problems and Parental Discipline Strategies.
  224. Sexual Dysfunction in Women With Type 1 Diabetes.

    22 April 2009

  225. Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis.
  226. Insulin Analogs versus Human Insulin in the Treatment of Patients with Diabetic Ketoacidosis: a randomized controlled trial.
  227. Physical fitness, dietary intake, and metabolic control in adolescents with type 1 diabetes.
  228. Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used.
  229. Breastfeeding and the basal insulin requirement in type 1 diabetic women.

    15 April 2009

  230. Nutrition Evidence-Based Guidelines for Treating Hyperlipidemia in Children With Type 1 Diabetes: A Case Presentation.
  231. Cardiac Autonomic Neuropathy (CAN) in Type-1 Diabetes Mellitus Patients and its Association with the Duration of Disease and Glycemic Control.
  232. Risk Factors for Urinary Incontinence Among Women With Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study.

    8 April 2009

  233. Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system.
  234. The full text of Institution of Basal-Bolus Therapy at Diagnosis for Children With Type 1 Diabetes Mellitus, previously reported, is now available in HTML and PDF formats.
  235. Predictors of Metabolic Control among Adolescents with Diabetes: A 4-Year Longitudinal Study.
  236. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.
  237. Road traffic accident risk in patients with diabetes mellitus receiving blood glucose-lowering drugs. Prospective follow-up study.
  238. Pediatric Atorvastatin in Diabetes Trial (PADIT): a pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus. Free full text available in PDF format.
  239. Web-based collaborative care for type 1 diabetes: a pilot randomized trial.
  240. Early autonomic dysfunction in type 1 diabetes: a reversible disorder?

    1 April 2009

  241. Type 1 Diabetes Among Adolescents: Reduced Diabetes Self-Care Caused by Social Fear and Fear of Hypoglycemia.
  242. Cognitive Function is Disrupted by Both Hypo- and Hyperglycemia in School-Aged Children with type 1 diabetes: A Field Study.
  243. Endurance capabilities of triathlon competitors with type 1 diabetes mellitus.
  244. Disturbed eating behaviors and eating disorders in type 1 diabetes: clinical significance and treatment recommendations.
  245. Prevalence and Correlates of Depression in Individuals With and Without Type 1 Diabetes.
  246. Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial.

    25 March 2009

  247. Changes in the Use of Analogue Insulins in 37 206 Children and Adolescents with Type 1 Diabetes in 275 German and Austrian Centers during the Last Twelve Years.
  248. Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes.
  249. A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients-A randomized controlled trial.
  250. Independent factors associated with depression in type 1 diabetes mellitus.
  251. Parenting Children With Diabetes: Exploring Parenting Styles on Children Living With Type 1 Diabetes Mellitus.
  252. Review of Family-centered Interventions to Enhance the Health Outcomes of Children With Type 1 Diabetes.
  253. Type 1 diabetes mellitus and periodontal disease: relationship to different clinical variables.
  254. HbA1c: how do we measure it and what does it mean?
  255. Whole Grain and Legume Acceptability Among Youths With Type 1 Diabetes.
  256. Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: A Meta-analysis.
  257. Lapses in medicaid coverage: impact on cost and utilization among individuals with diabetes enrolled in medicaid.
  258. Gestational diabetes; can a low glycemic index diet reduce the need for insulin? A randomised trial.
  259. Intensive versus Conventional Glucose Control in Critically Ill Patients; The NICE-SUGAR Study Investigators (free full text available in HTML and PDF formats). See also Glucose Control in the ICU — How Tight Is Too Tight? (free full text available in PDF format) and Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. (PDF)

    18 March 2009

  260. Insulin Glargine: a review 8 years after its introduction.
  261. Blindness and laser photocoagulation in patients with childhood-onset type 1 diabetes in Japan.
  262. Glycaemic trend during Ramadan in fasting diabetic subjects: a study from Pakistan.

    11 March 2009

  263. Institution of Basal-Bolus Therapy at Diagnosis for Children With Type 1 Diabetes Mellitus.
  264. Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis.
  265. Generic and Diabetes-specific Parent-Child Behaviors and Quality of Life Among Youth with Type 1 Diabetes.
  266. Peri-conceptional HbA1c and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes.

    4 March 2009

  267. Comparison of Accuracy and Safety of the SEVEN and the Navigator Continuous Glucose Monitoring Systems.
  268. Lipohypertrophy: does it matter in daily life? A study using a continuous glucose monitoring system.
  269. Educating Families on Real Time Continuous Glucose Monitoring: The DirecNet Navigator Pilot Study Experience.
  270. Perceived Diabetes Task Competence Mediates the Relationship of both Negative and Positive Affect with Blood Glucose in Adolescents with Type 1 Diabetes. See also Sad or Angry Teens Have Less Success With Diabetes Control.
  271. Are children with type 1 diabetes consuming a healthful diet?: a review of the current evidence and strategies for dietary change.
  272. Daily stressors and coping responses of children and adolescents with type 1 diabetes.
  273. NZSSD Position Statement on standardisation of reporting units for HbA1c and application of estimated average glucose (eAG).
  274. 25 February 2009

  275. Impact Of Carbohydrate Counting On Glycemic Control In Children With Type 1 Diabetes.
  276. Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK.
  277. Depressive Symptoms and Glycemic Control in Adolescents with Type 1 Diabetes: Mediational Role of Blood Glucose Monitoring.
  278. How effective is continuous glucose monitoring in intensively treated type 1 diabetes mellitus?
  279. Pedometers and Text Messaging to Increase Physical Activity: Randomized Controlled Trial of Adolescents with Type 1 Diabetes.
  280. Continuity and Change in Glycemic Control Trajectories from Adolescence to Emerging Adulthood: Relationships with Family Climate and Self-Concept in Type 1 Diabetes.
  281. Explaining the Adjustment of Adolescents with Type 1 Diabetes: The Role of Diabetes-Specific and Psychosocial Factors.
  282. Association Between Diabetes and Perinatal Depression Among Low-Income Mothers. See also Pregnant Women with Diabetes More Likely to Have Depression.

    18 February 2009

  283. Detection of Hypoglycemia with Continuous Interstitial and Traditional Blood Glucose Monitoring Using the FreeStyle Navigator Continuous Glucose Monitoring System.
  284. Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients.
  285. Factors Associated with Adherence to Continuous Subcutaneous Insulin Infusion in Pediatric Diabetes.
  286. Adults with type 1 diabetes eat a high-fat atherogenic diet that is associated with coronary artery calcium.
  287. Magnitude of Type 1 Diabetes Self-management in Youth: Health Care Needs Diabetes Educators.

    11 February 2009

  288. Significant vitamin D deficiency in youth with type 1 diabetes mellitus.
  289. Twenty-four hour Simultaneous Subcutaneous Basal-Bolus Administration of Insulin and Amylin in Adolescents with Type 1 Diabetes Decreases Post-Prandial Hyperglycemia.
  290. Effect of popular takeaway foods on blood glucose levels in type 1 diabetes mellitus patients on intensive insulin therapy.
  291. Long-Term Maintenance of Treatment Outcomes: "Diabetes Personal Trainer" Intervention for Youth with Type 1 Diabetes.
  292. Caring for people with type 1 diabetes mellitus engaging in disturbed eating or weight control: a qualitative study of practitioners' attitudes and practices.
  293. Explaining the Adjustment of Adolescents with Type 1 Diabetes: The Role of Diabetes-Specific and Psychosocial Factors.
  294. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
  295. Managing type 1 diabetes at school: an integrative review.
  296. Chronic kidney disease in long duration type 1 diabetes lasting more than 50 years.
  297. Economic family burden of metabolic control in children and adolescents with type 1 diabetes mellitus [in Mexico].

    28 January 2009

  298. Preventing Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension.
  299. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
  300. A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use.
  301. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
  302. Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio.
  303. Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents.
  304. The Effect of a Low-Glycemic Diet vs a Standard Diet on Blood Glucose Levels and Macronutrient Intake in Children with Type 1 Diabetes.
  305. Usability of a pre-filled insulin injection device in a 3-month observational survey of everyday clinical practice in Australia.
  306. Brief Report: Hope, Perceived Maternal Empathy, Medical Regimen Adherence, and Glycemic Control in Adolescents with Type 1 Diabetes.
  307. Health-related quality of life in intensively treated young patients with type 1 diabetes.
  308. Youth and parent education about diabetes complications: health professional survey.
  309. Urinary Incontinence Among Women With Type 1 Diabetes- How Common is it?

    21 January 2009

  310. Reducing postprandial hyperglycemia with adjuvant premeal pramlintide and postmeal insulin in children with type 1 diabetes mellitus.
  311. Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study. Free full text available in PDF format.
  312. Computerized Automated Reminder Diabetes System (CARDS): E-Mail and SMS Cell Phone Text Messaging Reminders to Support Diabetes Management.
  313. A randomized prospective study of insulin pump vs. insulin injection therapy in very young children with type 1 diabetes: 12-month glycemic, BMI, and neurocognitive outcomes.
  314. Effects of diabetes mellitus on periodontal and peri-implant conditions: update on associations and risks.
  315. Associations between physical activity, sedentary behavior, and glycemic control in a large cohort of adolescents with type 1 diabetes: the Hvidoere Study Group on Childhood Diabetes.
  316. Unchanged incidence of Microalbuminuria in Children with Type 1 Diabetes since 1986: A UK based inception cohort.
  317. Diabetic retinopathy is associated with early autonomic dysfunction assessed by exercise-related heart rate changes. Free full text available in HTML and PDF formats.
  318. Toward conceptual clarity in a critical parenting construct: parental monitoring in youth with chronic illness. Free full text available in HTML and PDF formats.
  319. Diet Soda Intake and Risk of Incident Metabolic Syndrome and Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis.
  320. Families who use a numbing cream for insulin pump infusion set or continuous glucose monintoring system insertions should read FDA Warns of Potential of Serious Side Effects with Topical Numbing Agents. See also FDA Public Health Advisory: Life-Threatening Side Effects with the Use of Skin Products Containing Numbing Ingredients for Cosmetic Procedures and Topical Anesthetics Stakeholder Letter from the FDA.

    14 January 2009

  321. The effect of insulin lispro on glycemic control in a large patient cohort.
  322. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
  323. The Median Is Not the Only Message: A Clinician's Perspective on Mathematical Analysis of Glycemic Variability and Modeling in Diabetes Mellitus. (PDF)
  324. A study of variability in glycaemia in children and adolescents with diabetes mellitus type 1 on treatment with insulin glargine.
  325. Evaluating the Accuracy, Reliability, and Clinical Applicability of Continuous Glucose Monitoring (CGM): Is CGM Ready for Real Time?
  326. Interactive Diary for Diabetes: A Useful and Easy-to-Use New Telemedicine System to Support the Decision-Making Process in Type 1 Diabetes.
  327. Training in flexible intensive insulin therapy improves quality of life, decreases the risk of hypoglycaemia and ameliorates poor metabolic control in patients with type 1 diabetes.
  328. Long-term review of driving potential following bilateral panretinal photocoagulation for proliferative diabetic retinopathy.
  329. Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study.

    7 January 2009

  330. "There's nothing I can't do: I just put my mind to it and I can do it": A qualitative analysis of how children with chronic disease and their parents account for and manage physical activity.
  331. The missing link: paediatric to adult transition in diabetes services.
  332. Treatment of diabetes mellitus using an external insulin pump: the state of the art.
  333. Changes in the internal structure of the human crystalline lens with diabetes mellitus type 1 and type 2.

[ Current Daily Care News | News from 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]



                 
  Home Return to Top

Last Updated: Thursday January 01, 2015 15:28:57
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.